Application of TCT to Research on Value in Screening for Cervical Cancer in Postmenopausal Women

Objective: To study the screening for cervical cancer in postmenopausal women in liquid-based cell test (TCT) application value. Methods: From January 2023 to March 2024 hospital check-ups and outpatient reached 400 cases of postmenopausal women, and they were TCT and HPV detection, during the study period to pathological diagnosis of numerical results as the standard, analysis of TCT detection application of screening for cervical cancer in postmenopausal women and the effect. Results: After the TCT detection, the inflammation group and normal group by use of HPV testing positive rate higher than other groups (P < 0.05). Hospital after pathological diagnosis and research, after the screening system found CIN Ⅰ level and above cases about 39 cases, the TCT and HPV detection rate of positive difference is not obvious, and there is no statistical significance (P > 0.05). Joint test analysis, the sensitivity and specificity were higher than that of TCT and HPV testing positive (P < 0.05). Conclusion: TCT detection screening for cervical cancer in postmenopausal women is of great importance to the application, if you can join HPV testing, help to improve the detection sensitivity, avoid missed diagnosis of problems, and then for treatment and later restore to lay a solid foundation.